Los Angeles Capital Management LLC Heron Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

$28.5 Billion
Q3 2025

A detailed history of Los Angeles Capital Management LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 246,413 shares of HRTX stock, worth $293,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares

246,413

Previous 266,128 7.41%

Holding current value

$293,231

Previous $550,000 42.73%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$1.21 - $2.23 $23,855 - $43,964	-19,715 Reduced 7.41%	246,413 $315,000
Q2 2025 Aug 06, 2025	BUY	$1.72 - $2.42 $341,119 - $479,946	198,325 Added 292.5%	266,128 $550,000
Q1 2025 May 05, 2025	BUY	$1.47 - $2.55 $220 - $382	150 Added 0.22%	67,803 $149,000
Q4 2024 Feb 04, 2025	SELL	$1.06 - $2.12 $162,371 - $324,743	-153,181 Reduced 69.36%	67,653 $103,000
Q3 2024 Nov 04, 2024	SELL	$1.73 - $3.67 $31,252 - $66,298	-18,065 Reduced 7.56%	220,834 $439,000
Q2 2024 Aug 05, 2024	SELL	$2.32 - $3.86 $590,126 - $981,848	-254,365 Reduced 51.57%	238,899 $836,000
Q1 2024 Apr 05, 2024	SELL	$1.71 - $3.06 $36,103 - $64,605	-21,113 Reduced 4.1%	493,264 $1.37 Million
Q4 2023 Feb 06, 2024	BUY	$0.54 - $1.82 $92,475 - $311,675	171,250 Added 49.91%	514,377 $874,000
Q3 2023 Nov 06, 2023	BUY	$0.97 - $1.8 $3,543 - $6,575	3,653 Added 1.08%	343,127 $353,000
Q2 2023 Aug 03, 2023	SELL	$1.11 - $2.88 $406,485 - $1.05 Million	-366,203 Reduced 51.89%	339,474 $393,000
Q1 2023 May 04, 2023	BUY	$1.51 - $3.25 $812,416 - $1.75 Million	538,024 Added 320.92%	705,677 $1.07 Million
Q4 2022 Feb 06, 2023	SELL	$2.25 - $4.67 $12,150 - $25,218	-5,400 Reduced 3.12%	167,653 $419,000
Q3 2022 Nov 02, 2022	BUY	$2.66 - $5.37 $460,320 - $929,294	173,053 New	173,053 $730,000
Q2 2021 Aug 05, 2021	SELL	$13.27 - $18.48 $211,523 - $294,571	-15,940 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$14.49 - $20.72 $140,697 - $201,191	-9,710 Reduced 37.86%	15,940 $258,000
Q4 2020 Feb 04, 2021	SELL	$14.61 - $22.14 $730 - $1,107	-50 Reduced 0.19%	25,650 $543,000
Q3 2020 Nov 02, 2020	BUY	$13.67 - $17.77 $16,814 - $21,857	1,230 Added 5.03%	25,700 $381,000
Q2 2020 Aug 05, 2020	BUY	$10.89 - $21.47 $101,015 - $199,155	9,276 Added 61.05%	24,470 $359,000
Q1 2020 May 04, 2020	BUY	$10.23 - $24.56 $155,434 - $373,164	15,194 New	15,194 $178,000
Q2 2019 Jul 29, 2019	SELL	$16.93 - $26.22 $252,087 - $390,415	-14,890 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$23.15 - $28.34 $111,120 - $136,032	-4,800 Reduced 24.38%	14,890 $364,000
Q4 2018 Feb 11, 2019	BUY	$22.03 - $32.01 $256,429 - $372,596	11,640 Added 144.6%	19,690 $511,000
Q3 2018 Nov 05, 2018	BUY	$30.0 - $40.85 $241,500 - $328,842	8,050 New	8,050 $255,000

Others Institutions Holding HRTX

# of Institutions

183

Shares Held

127M

Call Options Held

1.56M

Put Options Held

27.1K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $141M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Heron Therapeutics, Inc. Transaction History